Tech reversal a warning?

Eleanor Creagh

Australian Market Strategist, Saxo

Summary:  Heading into the Q2 earnings season in the US, equities have been treading water with most major indices remaining range bound searching for a catalyst to breakout, with the exception of the Nasdaq 100 where mega-cap tech stocks have continued to set new highs on declining volumes. However, price action on Wall Street overnight is signalling sentiment is beginning to shift and a near term top for the Nasdaq 100 could be in. After setting a fresh record high, the index sharply reversed closing more than 2% lower.


The sharp reversal in the market leaders overnight has soured sentiment in Asia today, along with plummeting GDP data from Singapore and growing tensions over the South China Sea. The “buy now, pay later” sector on the ASX 200 which trades at lofty multiples having closely followed the almost parabolic surge in US mega-cap tech stocks is feeling the heat today following the sharp reversals seen across key technology names in the US overnight.

This as investors weigh policy support against the rising COVID-19 case count ahead of what will be a tumultuous ride with respect to quarterly updates. Investors have been flying blind when it comes to corporate earnings with many companies withdrawing guidance, leading to a lack of visibility and increased dispersion amongst analyst estimates.

For the technology sector in particular, the bar is high. Valuations are extended as investors have sought refuge in the sector with the acceleration of secular growth themes like working from home, digitisation/Saas, cloud computing and e-commerce as a result of the global pandemic. The acceleration of these secular thematics coupled with lower debt levels, higher free cash flow yields, and earnings duration profiles with high forecast future cash flows at record low rates has allowed investors to value the sector more richly. These extended valuations leave little margin for error should the companies disappoint the lofty expectations. With cross asset correlations remaining high, and elevated volatility indicating a degree of underlying fragility remains, ructions in the technology sector have the capacity to overflow quickly to the broader risk asset spectrum, which of course includes the ASX 200. With the Nasdaq having rebounded over 50% from late March, momentum is on side will the bulls and resistance seems futile. However, we remain vigilant as complacency reigns for now, but risk typically builds slowly, and when sentiment shifts, liquidity quickly disappears. Then the previous stability in the seemingly never-ending melt up is destabilising in itself, with everyone rushing for the exits at once. The overnight moves could well be the harbinger of more pain. Long growth/short value positioning is at historical extremes and a reversal in this positioning could be painful, with a correction well overdue.

Although risk assets have rebounded rapidly alongside an abundance of liquidity and a resumption in activity post lockdown, there is a growing fault line between reality and market pricing. The scars of the global pandemic that leave realities of persistently high unemployment with permanent job losses mounting, prolonged social distancing measures and other restrictions impinging business margins, and resounding uncertainties that weigh on business and consumer confidence are yet to be felt. Governments and central banks have stepped in quickly in response to the global pandemic, with liquidity taps turned in full force to cushion the impact the sudden economic stop. This liquidity has papered over the cracks for now, but the new “liquid insolvent” business model will eventually wear thin as these actions buy time, not solvency and fundamentals eventually trump liquidity. This alongside the growing COVID-19 case count globally, with many countries still battling the virus into Q3, the lifting of restrictions is pausing and high frequency data shows consumers are becoming more cautious with confidence, mobility, footfall, and restaurant bookings dropping off. Beyond the initial bounce back following a period of pent up demand, it seems the recovery is now plateauing and caution remains which means the speed of the initial bounce back will not be maintained. The resurgence of the virus within Australia where community transmission has taken off in Victoria has seen Melbourne once more in lockdown and we will soon find if the contact testing and tracing strategy has worked in NSW with cases beginning to creep higher. With consumers becoming more cautious, the marginal propensity to spend declines thus weighing on both the speed and shape of the nascent recovery. Covid-19 may have started as a health crisis, but it quickly morphed into an economic and social one. However, the problem with the root cause of this crisis being a global pandemic, there remains a huge amount of uncertainty as no one, not even the epidemiologists can tell us definitively how this plays out, and some experts are on record saying it could be 2 years before a vaccine can be successfully implemented.

So far, the concerns above have mattered little with respect to price action and risk assets have managed to shrug off the prospect of a stalling economic recovery in favour of a broad based melt up with global equities rebounding close to 40% since March lows. The underlying support from central banks, who incipient bubble or not, have pledged to continue to do whatever is necessary in order to detach asset prices from fundamentals puts a floor under risk assets for now, but does not prevent corrective moves. Investors who have for years been conditioned by the central bank put to buy dips have set aside the economic realities in favour of momentum and speculative stimulus driven markets. However, given current extended positioning and sentiment, there is plenty of opportunity for more two-way price action.

With this dynamic in the play, the dissonance between market pricing and reality grows, leading to bumps along the road. This fault line will become more visible as a failure to flatten the first wave of the virus prevents activity from normalising in 2H. For both businesses and consumers, the uncertainty is pervasive. Investors have been looking through the earnings hit, to the recovery, but the realities of a plateauing recovery and failure to return to pre-crisis levels of output that sees businesses operating revenues and cash flows squeezed for a prolonged period will eventually catch up.

With risk assets oscillating between the prospect of continued government and central bank support matched with a stalling global recovery, price action could remain range bound with volatility elevated for some time. When we look at volatility, the VIX remains elevated, currently at 32 and well above the 22 level, which is generally considered the long-term equilibrium in the term structure. With respect to this signal, it is fair to say volatility has failed to settle back within a lower range and has not given investors the signal that the “bear market” is over, in many ways this is not a “normal” bull market and confirms the speculative flavour of the current environment. Perhaps unsurprising when the only real bull market is in intervention. 

Disclaimer

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-sg/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Markets or its affiliates.

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.